AU Patent

AU2009204700B2 — Compounds having CRTH2 antagonist activity

Assigned to Atopix Therapeutics Ltd · Expires 2013-07-04 · 13y expired

What this patent protects

Compounds of general formula (I) wherein W is chloro or fluoro; R

USPTO Abstract

Compounds of general formula (I) wherein W is chloro or fluoro; R

Drugs covered by this patent

Patent Metadata

Patent number
AU2009204700B2
Jurisdiction
AU
Classification
—
Expires
2013-07-04
Drug substance claim
No
Drug product claim
No
Assignee
Atopix Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.